Cellectis (CLLS) Net Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 49,253.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 506.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -569.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7,218.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | 301,610.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 301,610.00 |
| Dec 31, 2025 | -83,184.00 |
| Sep 30, 2025 | 332,132.00 |
| Jun 30, 2025 | 9,426.00 |
| Dec 31, 2024 | -19,714.00 |
| Sep 30, 2024 | 53,836.00 |
| Dec 31, 2023 | -1.45 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -524,920.00 |
| Mar 31, 2023 | -340,357.00 |
| Dec 31, 2022 | 85,227.00 |
| Sep 30, 2022 | -295,341.00 |
| Jun 30, 2022 | 301,531.00 |
| Dec 31, 2021 | 294,457.00 |
| Sep 30, 2021 | 268,057.00 |
| Jun 30, 2021 | 9,434.00 |
| Dec 31, 2020 | 11,483.00 |
| Sep 30, 2020 | -5,520.00 |
| Jun 30, 2020 | -83,355.00 |
| Mar 31, 2020 | 32,200.00 |
| Dec 31, 2019 | -62,247.00 |
| Sep 30, 2019 | -19,954.00 |
| Jun 30, 2019 | -137,107.00 |
| Mar 31, 2019 | -193,909.00 |
| Jun 30, 2018 | -26,423.00 |
| Mar 31, 2018 | -37,007.00 |